| P50 | author | Jacob Rosenberg | Q85827214 |
| | Ismail Gögenur | Q56550094 |
| P2093 | author name string | Lars Peter Holst Andersen | |
| | Nathja Groth Harpsøe | |
| P2860 | cites work | Endogenous Melatonin Levels and the Fate of Exogenous Melatonin: Age Effects | Q61784266 |
| | Bioavailability of melatonin in humans after day-time administration of D(7) melatonin | Q73093898 |
| | Variable bioavailability of oral melatonin | Q73199929 |
| | The absolute bioavailability of oral melatonin | Q73961833 |
| | Time course of saliva and serum melatonin levels after ingestion of melatonin | Q74653104 |
| | Evaluation of an oral pulsatile delivery system for melatonin in humans | Q77070915 |
| | Soft gel capsules improve melatonin's bioavailability in humans | Q87420608 |
| | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 |
| | Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 |
| | Melatonin in humans | Q28300884 |
| | One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? | Q34596674 |
| | Plasma concentrations of melatonin in man following oral absorption of different preparations | Q34622566 |
| | Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity | Q35825510 |
| | Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial | Q36749111 |
| | Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults | Q36928856 |
| | A systematic review of peri-operative melatonin. | Q38212332 |
| | Oral administration and distribution of melatonin in human serum, saliva and urine | Q41377833 |
| | Effects of preoperative oral melatonin medication on postoperative analgesia, sleep quality, and sedation in patients undergoing elective prostatectomy: a randomized clinical trial | Q43148737 |
| | Pharmacokinetics of orally administered melatonin in critically ill patients | Q43195642 |
| | Melatonin reduces oxidative stress in surgical neonates. | Q44766068 |
| | Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection | Q44902476 |
| | Influence of cigarette smoking on melatonin levels in man. | Q46433552 |
| | The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism | Q46587398 |
| | Utility of melatonin to treat surgical stress after major vascular surgery--a safety study | Q46800761 |
| | Melatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteers | Q46856808 |
| | The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy | Q46932674 |
| | Pharmacokinetics of melatonin in human sexual maturation. | Q51033617 |
| | Bioavailability of oral melatonin in humans. | Q52431867 |
| | Increased bioavailability of oral melatonin after fluvoxamine coadministration. | Q55033613 |
| | PET and plasma pharmacokinetic studies after bolus intravenous administration of [11C]melatonin in humans | Q57700856 |
| P433 | issue | 8 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| | systematic review | Q1504425 |
| P304 | page(s) | 901-909 | |
| P577 | publication date | 2015-05-27 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Clinical pharmacokinetics of melatonin: a systematic review | |
| P478 | volume | 71 | |